Biomarkers
Olfactory Dysfunction in Incidental Lewy Body Disease and Parkinson’s Disease: An Update
by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan
December 1, 2022
No Comments
by Shemonti Hasan, MD; Charles H. Adler, MD, PhD; Nan
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD
by Aline Hajj, PharmD, PhD; Souheil Hallit, PharmD, MSc, MPH,
by Michelle D. Po, PhD; Roberto Gomeni, PhD, HDR, FCP; and
by Peta Stapleton, PhD; Dawson Church, PhD; Oliver Baumann, PhD; and
by Plamen Tzvetanov, MD, Phd, DSc, FRCP; Ivan Lisichkov, MD,
by Larry Alphs, MD, PhD; Dong-Jing Fu, MD, PhD; David
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD
by Laura Villarreal-Martinez, MD; Laura Elia MartÍnez-Garza, MD; Iram Pablo
by Carolyn O’Donnell, PharmD; Tammie Lee Demler, PharmD, MBA, BCGP, BCPP; and
